Schizophrenia News and Research

Latest Schizophrenia News and Research

Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate

The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocked in court. It makes deep cuts in state programs that will have unwelcome repercussions in years to come. And if the revenue projections prove to be as overly optimistic as they seem, there will be more damaging cuts to education, child care and health services. Nevertheless, it's a more earnest effort to clean up the state's budget mess than Sacramento has seen in a decade or more.

30 Jun 2011

BioLineRx initiates enrollment in BL-1020 Phase II/III trial against schizophrenia

BioLineRx, a biopharmaceutical development company, announced today the enrollment of the first patient in the Phase II/III CLARITY clinical trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.

28 Jun 2011

Synthetic cannabis ban in NSW from 1st of July

Kronic and other named synthetic drugs that induce effects similar to cannabis will be banned in NSW from July 1. NSW Mental Health Minister Kevin Humphries announced this saying use of the products sold online and at retail outlets have led to warnings from doctors. He added that the state government will ban the products under existing legislation.

28 Jun 2011

Omeros identifies compounds that interact with orphan GPCRs associated with leukemia

Omeros Corporation today reported that it has identified compounds that interact with orphan G protein-coupled receptors (GPCRs) P2Y8 and OPN4. P2Y8 (also known as P2RY8) is associated with acute lymphoblastic leukemia (ALL), an aggressive cancer of the white blood cells.

27 Jun 2011

EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease

EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it recently initiated a Phase 1 clinical trial of EVP-0962, its potent and selective gamma secretase modulator (GSM), in healthy volunteers.

27 Jun 2011

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

BioLineRx, a biopharmaceutical drug development company, and Yissum Research Development Company Ltd., the Technology Transfer Company of the Hebrew University of Jerusalem, announced today that they have signed a worldwide, exclusive license agreement for BioLineRx to develop and commercialize BL-7040, an orally available Phase II ready molecule for treating Inflammatory Bowel Disease (IBD) and other inflammatory diseases.

27 Jun 2011

Stresses can change gene expression without DNA sequence change

None of us are strangers to stress of various kinds. It turns out the effects of all those stresses can change the fate of future generation, influencing our very DNA without any change to the underlying sequence of As, Gs, Ts and Cs. Now, researchers reporting in the June 24th issue of Cell, a Cell Press publication, have new evidence that helps to explain just how these epigenetic changes really happen.

24 Jun 2011

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the Company's proprietary Vesicular Monoamine Transporter 2 inhibitor, NBI-98854.

24 Jun 2011

Hunger hormone likely to cause stress-linked complex eating behaviors

We are one step closer to deciphering why some stressed people indulge in chocolate, mashed potatoes, ice cream and other high-calorie, high-fat comfort foods. UT Southwestern Medical Center-led findings, in a mouse study, suggest that ghrelin - the so-called "hunger hormone" - is involved in triggering this reaction to high stress situations.

24 Jun 2011

‘City slickers’ at increased brain stress: Study

German and Canadian neuroscientists have shown that living in a city or even being raised in one is associated with differences in the way the brain handles stress. They write in Nature that this is the first time researchers have used functional magnetic resonance imaging (fMRI) to identify specific brain regions that are affected by urban life.

23 Jun 2011

New surprising details about flow of neurotransmitters between brain neurons

Two studies featuring research from Weill Cornell Medical College have uncovered surprising details about the complex process that leads to the flow of neurotransmitters between brain neurons -- a dance of chemical messages so delicate that missteps often lead to neurological dysfunction.

23 Jun 2011

Urban dwellers at greater risk of mental illness: Study

A new study shows that living in a city increases the risk of developing a mental disorder, including depression and schizophrenia, compared to people who live in non-urban areas. The findings of the has implications for around half of the world's population who live in cities.

23 Jun 2011

Scientists observe key aspects of how memory circuits in the brain refine themselves

Scientists at the University of Michigan Health System have for the first time demonstrated how memory circuits in the brain refine themselves in a living organism through two distinct types of competition between cells.

23 Jun 2011

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.

22 Jun 2011

University of Helsinki psychiatric professor to receive Nordic Public Health Prize 2011

The Nordic Public Health Prize 2011 will be awarded to Professor of Psychiatry Jouko Lönnqvist for his internationally acclaimed research on the causes, spread and prevention of mental illness at population- and individual level.

21 Jun 2011

Johns Hopkins scientists develop mouse model for autism spectrum disorders

In an effort to unravel the tangled biology of autism, Johns Hopkins scientists have created a mouse model that mimics a human mutation of a gene known to be associated with autism spectrum disorders.

21 Jun 2011

Study: Dyslexia gene controls cilia in brain neurons

Scientists at Karolinska Institutet in Sweden have discovered that a gene linked to dyslexia has a surprising biological function: it controls cilia, the antenna-like projections that cells use to communicate.

20 Jun 2011

Risperidone recall by J&J

Ortho-McNeil-Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, recalled about 16,000 bottles of its Risperdal schizophrenia drug on reports of an uncharacteristic odor. The recall affects one lot that was shipped between Aug. 27, 2010, and Feb. 15, 2011.

19 Jun 2011

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Structural biologists at Cold Spring Harbor Laboratory (CSHL) have obtained a precise molecular map of the binding site for an allosteric inhibitor in a subtype of the NMDA (N-methyl-D-aspartate) receptor, which is commonly expressed in brain cells.

17 Jun 2011

Life Technologies introduces CytoTune-iPS Reprogramming Kit

Life Technologies Corporation today announced the launch of CytoTune-iPS Reprogramming Kit -- research technology that provides far improved efficiency over standard methods to develop induced pluripotent stem cells from human somatic cells.

16 Jun 2011

Schizophrenia News and Research

Latest Schizophrenia News and Research

Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate

BioLineRx initiates enrollment in BL-1020 Phase II/III trial against schizophrenia

Synthetic cannabis ban in NSW from 1st of July

Omeros identifies compounds that interact with orphan GPCRs associated with leukemia

EnVivo initiates EVP-0962 GSM Phase 1 clinical trial for Alzheimer’s disease

Yissum, BioLineRx sign license deal to develop and commercialize BL-7040 for IBD

Stresses can change gene expression without DNA sequence change

USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia

Hunger hormone likely to cause stress-linked complex eating behaviors

‘City slickers’ at increased brain stress: Study

New surprising details about flow of neurotransmitters between brain neurons

Urban dwellers at greater risk of mental illness: Study

Scientists observe key aspects of how memory circuits in the brain refine themselves

Naurex commences GLYX-13 Phase II trial in treatment-resistant depression

University of Helsinki psychiatric professor to receive Nordic Public Health Prize 2011

Johns Hopkins scientists develop mouse model for autism spectrum disorders

Study: Dyslexia gene controls cilia in brain neurons

Risperidone recall by J&J

Precisely mapped allosteric binding site will facilitate design of drugs with minimal side effects

Life Technologies introduces CytoTune-iPS Reprogramming Kit

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Schizophrenia News and Research

Latest Schizophrenia News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in